Ju Y, Xiao W, Mathis B, Shi Y
Front Immunol. 2025; 16:1514780.
PMID: 39995670
PMC: 11848521.
DOI: 10.3389/fimmu.2025.1514780.
Aubert A, Goeres J, Liu A, Kao M, Richardson K, Jung K
Front Immunol. 2025; 15:1484462.
PMID: 39885984
PMC: 11779620.
DOI: 10.3389/fimmu.2024.1484462.
Vitulano C, Forcina G, Colosimo S, Frattolillo V, Villani A, Marzuillo P
Mol Diagn Ther. 2025; 29(2):183-193.
PMID: 39820940
DOI: 10.1007/s40291-024-00761-7.
Li R, Zhang F, Wang L, Wang S, Zhou M, Wang J
Int J Mol Sci. 2025; 26(1.
PMID: 39796249
PMC: 11720202.
DOI: 10.3390/ijms26010395.
Yu M, Wang S, Lin D
Int J Mol Sci. 2025; 26(1.
PMID: 39796102
PMC: 11720555.
DOI: 10.3390/ijms26010245.
Cardiac fibroblast BAG3 regulates TGFBR2 signaling and fibrosis in dilated cardiomyopathy.
Wang B, Morsink M, Kim S, Luo L, Zhang X, Soni R
J Clin Invest. 2025; 135(1).
PMID: 39744939
PMC: 11684812.
DOI: 10.1172/JCI181630.
Exploring the Role of the TGF-β Signaling Pathway in Colorectal Precancerous Polyps Biochemical Genetics.
Sadri S, Aghajani A, Soleimani H, Ghorbani Kalkhajeh S, Nazari H, Brouki Milan P
Biochem Genet. 2024; .
PMID: 39636332
DOI: 10.1007/s10528-024-10988-y.
Transcriptional regulators ensuring specific gene expression and decision-making at high TGFβ doses.
Hartmann L, Kristofori P, Li C, Becker K, Hexemer L, Bohn S
Life Sci Alliance. 2024; 8(1).
PMID: 39542693
PMC: 11565188.
DOI: 10.26508/lsa.202402859.
IQGAP3 signalling mediates intratumoral functional heterogeneity to enhance malignant growth.
Shimura M, Matsuo J, Pang S, Jangphattananont N, Hussain A, Rahmat M
Gut. 2024; 74(3):364-386.
PMID: 39438124
PMC: 11874294.
DOI: 10.1136/gutjnl-2023-330390.
Distinct phenotypes induced by acute hypoxia and TGF-β1 in human adult cardiac fibroblasts.
Khalil N, Rexius-Hall M, Escopete S, Parker S, McCain M
J Mol Cell Cardiol Plus. 2024; 9.
PMID: 39329164
PMC: 11423773.
DOI: 10.1016/j.jmccpl.2024.100080.
NY-ESO-1 antigen: A promising frontier in cancer immunotherapy.
Alsalloum A, Shevchenko J, Sennikov S
Clin Transl Med. 2024; 14(9):e70020.
PMID: 39275923
PMC: 11399778.
DOI: 10.1002/ctm2.70020.
CCL9/CCR1 axis-driven chemotactic nanovesicles for attenuating metastasis of SMAD4-deficient colorectal cancer by trapping TGF-.
Niu B, Tian T, Wang L, Tian Y, Tian T, Guo Y
Acta Pharm Sin B. 2024; 14(8):3711-3729.
PMID: 39220887
PMC: 11365421.
DOI: 10.1016/j.apsb.2024.05.009.
Roles of SMAD and SMAD-Associated Signaling Pathways in Nerve Regeneration Following Peripheral Nerve Injury: A Narrative Literature Review.
Lee J, Yon D, Choi Y, Lee J, Yeo J, Kim S
Curr Issues Mol Biol. 2024; 46(7):7769-7781.
PMID: 39057101
PMC: 11276098.
DOI: 10.3390/cimb46070460.
Analyzing small RNA sequences from canine stem cell-derived extracellular vesicles primed with TNF-α and IFN-γ and exploring their potential in lung repair.
Lee J, Jeong Y, Kim Y, Yun J, Ahn J, Chung J
Front Vet Sci. 2024; 11:1411886.
PMID: 39011319
PMC: 11246880.
DOI: 10.3389/fvets.2024.1411886.
Amelioration of breast cancer therapies through normalization of tumor vessels and microenvironment: paradigm shift to improve drug perfusion and nanocarrier permeation.
Famta P, Shah S, Vambhurkar G, Pandey G, Bagasariya D, Kumar K
Drug Deliv Transl Res. 2024; 15(2):389-406.
PMID: 39009931
DOI: 10.1007/s13346-024-01669-9.
Dysregulation of exosomal miRNAs and their related genes in head and neck cancer patients.
Rizwan M, Mahjabeen I, Ashraf N, Arshad M, Haris M, Kayani M
Future Oncol. 2024; 20(21):1479-1493.
PMID: 38861304
PMC: 11441060.
DOI: 10.1080/14796694.2024.2351355.
Exploring the Role of GDF-15 in Inflammatory Bowel Disease: A Case-Controlled Study Comparing Crohn's Disease and Ulcerative Colitis with Non-Inflammatory Controls.
Kucerka O, Blahutova M, Kosek V, Minarikova P, Horacek J, Urbanek P
Metabolites. 2024; 14(4).
PMID: 38668313
PMC: 11051727.
DOI: 10.3390/metabo14040185.
Enhanced cellular therapy: revolutionizing adoptive cellular therapy.
Xu M, Zeng N, Liu C, Sun J, An Y, Zhang S
Exp Hematol Oncol. 2024; 13(1):47.
PMID: 38664743
PMC: 11046957.
DOI: 10.1186/s40164-024-00506-6.
The TGF-β superfamily as potential therapeutic targets in pancreatic cancer.
Tindall R, Bailey-Lundberg J, Cao Y, Ko T
Front Oncol. 2024; 14:1362247.
PMID: 38500662
PMC: 10944957.
DOI: 10.3389/fonc.2024.1362247.
Postbiotic butyrate: role and its effects for being a potential drug and biomarker to pancreatic cancer.
Elango A, Nesam V, Sukumar P, Lawrence I, Radhakrishnan A
Arch Microbiol. 2024; 206(4):156.
PMID: 38480544
DOI: 10.1007/s00203-024-03914-8.
